Application 017962

Type
NDA
Sponsor
US PHARMS HOLDINGS I

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PARLODELBROMOCRIPTINE MESYLATETABLET;ORALEQ 2.5MG BASEYesNo
002PARLODELBROMOCRIPTINE MESYLATECAPSULE;ORALEQ 5MG BASEYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017962-001PARLODELBROMOCRIPTINE MESYLATEEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982
N017962-002PARLODELBROMOCRIPTINE MESYLATEEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N017962-001AB
N017962-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-0131067a03dcf5…
2025-08-23 18:47 UTC2025-08N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-016a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-0103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-012680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-015bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-0179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-011e350fbaab3a…
2024-05-31 18:47 UTC2024-05N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-018072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-015c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N017962-002PARLODELEQ 5MG BASECAPSULE / ORALABRLD1982-03-015d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N017962-002PARLODELEQ 5MG BASECAPSULE / ORALABRLD1982-03-014b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**CAPSULE / ORALABRLD1982-03-0174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALABRLD1982-03-01bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N017962-001PARLODELEQ 2.5MG BASETABLET / ORALABRLD, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N017962-002PARLODELEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**CAPSULE / ORALABRLD1982-03-01782e0a99824c…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N017962-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017962-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017962-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017962-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N017962-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017962-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017962-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017962-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017962-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017962-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017962-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017962-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017962-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017962-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017962-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017962-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017962-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017962-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N017962-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N017962-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017962-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017962-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017962-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017962-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017962-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017962-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N017962-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N017962-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017962-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017962-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N017962-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N017962-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N017962-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N017962-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N017962-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N017962-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N017962-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N017962-002AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N017962-001AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N017962-002AB1782e0a99824c…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Bromocriptine MesylateBROMOCRIPTINE MESYLATEANI Pharmaceuticals, Inc.17f3a343-1782-4799-95ba-31dfe93be2cf2026-07-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 017962
application number: NDA017962
Bromocriptine MesylateBROMOCRIPTINE MESYLATEAmerican Health Packagingddd292a5-72af-448f-8b88-cc4fd99ec7832026-06-12Warnings, Adverse reactionsExact identifier
application applno (NDA): 017962
application number: NDA017962

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
30698-201Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
30698-201Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
30698-201Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
30698-202Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
30698-202Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
30698-202Parlodelbromocriptine mesylateValidus Pharmaceuticals LLCNDACurrent
63304-158BROMOCRIPTINE MESYLATEbromocriptine mesylateSun Pharmaceutical Industries, Inc.NDACurrent
63304-158BROMOCRIPTINE MESYLATEbromocriptine mesylateSun Pharmaceutical Industries, Inc.NDACurrent
63304-962BROMOCRIPTINE MESYLATEbromocriptine mesylateSun Pharmaceutical Industries, Inc.NDACurrent
63304-962BROMOCRIPTINE MESYLATEbromocriptine mesylateSun Pharmaceutical Industries, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68071SUPPL2021-07-14
68064SUPPL2021-07-13
61509SUPPL2020-01-03
61306SUPPL2019-12-17
33376SUPPL2012-01-06
13964SUPPL2012-01-06
13963SUPPL2012-01-06
11098SUPPL2012-01-06
40765SUPPL2006-05-08
20097SUPPL2006-05-08
33375SUPPL2005-11-17
13962SUPPL2005-11-17
13961SUPPL2005-11-17
11097SUPPL2005-11-17